SS
RVMD icon

Steve Schonfeld’s Revolution Medicines RVMD Stock Holding History

Steve Schonfeld’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.38M Buy
+34,061
New +$4.98M 0.02% 553
2025
Q4 		– Sell
-34,575
Closed -$1.61M – 2522
2025
Q3 		$1.61M Buy
34,575
+21,552
+165% +$844K 0.01% 1148
2025
Q2 		$479K Sell
13,023
-6,647
-34% -$255K ﹤0.01% 1551
2025
Q1 		$696K Sell
19,670
-330
-2% -$13.4K ﹤0.01% 1441
2024
Q4 		$875K Buy
20,000
+12,579
+170% +$635K 0.01% 1176
2024
Q3 		$337K Buy
+7,421
New +$323K ﹤0.01% 1606

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Steve Schonfeld's RVMD Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Revolution Medicines (RVMD) in Q2 2026: 34,061 shares worth $6.38M. The stake represents 0.02% of the portfolio and ranks #553 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in RVMD as recently as Q3 2025.

Steve Schonfeld first reported a position in RVMD in Q3 2024 and has held it in 6 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Steve Schonfeld held 34,061 shares of Revolution Medicines worth $6.38M as of Q2 2026.
  • Revolution Medicines was a new Steve Schonfeld position in Q2 2026.
  • Revolution Medicines made up 0.02% of Steve Schonfeld's portfolio in Q2 2026, its #553 holding.
  • Steve Schonfeld first reported a position in Revolution Medicines in Q3 2024 and has held it in 6 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.